ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY
Anti-CD19 B4 antibodies with modified variable regions are disclosed. The modified anti-CD19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a T-...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
08.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Anti-CD19 B4 antibodies with modified variable regions are disclosed. The modified anti-CD19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a T-cell response. |
---|---|
Bibliography: | Application Number: US201816126296 |